Trial Profile
Special Drug Use Investigation for AMERGE Tablet.
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 30 Aug 2023
Price :
$35
*
At a glance
- Drugs Naratriptan (Primary)
- Indications Migraine
- Focus Adverse reactions
- Acronyms AMERGE
- Sponsors GlaxoSmithKline; GSK
- 01 Jul 2014 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov record.
- 25 Jan 2013 Planned End Date changed from 1 Feb 2012 to 1 Feb 2014 as reported by ClinicalTrials.gov.
- 03 Jun 2011 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.